NO20032149L - Nye anvendelser av kombinerte, selektive dopamin D2- reseptorantagonister og5-HT1A-reseptoragonister - Google Patents
Nye anvendelser av kombinerte, selektive dopamin D2- reseptorantagonister og5-HT1A-reseptoragonisterInfo
- Publication number
- NO20032149L NO20032149L NO20032149A NO20032149A NO20032149L NO 20032149 L NO20032149 L NO 20032149L NO 20032149 A NO20032149 A NO 20032149A NO 20032149 A NO20032149 A NO 20032149A NO 20032149 L NO20032149 L NO 20032149L
- Authority
- NO
- Norway
- Prior art keywords
- new applications
- selective dopamine
- combined selective
- ht1a
- receptor antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Nutrition Science (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00124814 | 2000-11-14 | ||
| PCT/EP2001/012325 WO2002039988A2 (en) | 2000-11-14 | 2001-10-25 | Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20032149D0 NO20032149D0 (no) | 2003-05-13 |
| NO20032149L true NO20032149L (no) | 2003-05-13 |
Family
ID=8170368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032149A NO20032149L (no) | 2000-11-14 | 2003-05-13 | Nye anvendelser av kombinerte, selektive dopamin D2- reseptorantagonister og5-HT1A-reseptoragonister |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20040014788A1 (no) |
| EP (1) | EP1333821A2 (no) |
| JP (1) | JP2004513915A (no) |
| KR (1) | KR20030065511A (no) |
| CN (1) | CN1474688A (no) |
| AR (1) | AR035503A1 (no) |
| AU (1) | AU2002221744A1 (no) |
| BR (1) | BR0115297A (no) |
| CA (1) | CA2428519A1 (no) |
| CZ (1) | CZ20031434A3 (no) |
| HU (1) | HUP0302761A2 (no) |
| MX (1) | MXPA03004249A (no) |
| NO (1) | NO20032149L (no) |
| PL (1) | PL361462A1 (no) |
| RU (1) | RU2283648C2 (no) |
| SK (1) | SK6392003A3 (no) |
| WO (1) | WO2002039988A2 (no) |
| ZA (1) | ZA200304602B (no) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL2009131C2 (en) * | 2012-07-05 | 2014-01-07 | Stichting Vu Vumc | Compound and use of compound to prepare a radiollabelled compound. |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0465254B1 (en) * | 1990-07-06 | 1996-11-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused thiophene compounds and uses thereof |
| US5314888A (en) * | 1992-02-21 | 1994-05-24 | Trustees Of Tufts College | Veterinary method for treating inappropriate elimination of urine in household pets |
| GB9302622D0 (en) * | 1993-02-10 | 1993-03-24 | Wellcome Found | Heteroaromatic compounds |
| ZA954688B (en) * | 1994-06-08 | 1996-01-29 | Lundbeck & Co As H | Serotonin 5-HT1A and dopamin D2 receptor ligands |
| EP0707007B1 (en) * | 1994-10-14 | 2001-12-12 | MERCK PATENT GmbH | (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane as CNS active agent |
| US5554383A (en) * | 1995-04-06 | 1996-09-10 | Trustees Of Tufts College | Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression |
| AU6517196A (en) * | 1995-07-13 | 1997-02-10 | Knoll Aktiengesellschaft | Piperazine derivatives as therapeutic agents |
| GB9514380D0 (en) * | 1995-07-13 | 1995-09-13 | Knoll Ag | Therapeutic agents |
| EP0900792B1 (en) * | 1997-09-02 | 2003-10-29 | Duphar International Research B.V | Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists |
| ATE253058T1 (de) * | 1997-09-02 | 2003-11-15 | Duphar Int Res | Piperidin- und piperazin derivate als 5-ht1- rezeptor-agonisten |
| US6242456B1 (en) * | 1998-03-09 | 2001-06-05 | Trustees Of Tufts College | Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors |
| WO1999055672A2 (en) * | 1998-04-29 | 1999-11-04 | American Home Products Corporation | Antipsychotic indolyl derivatives |
| UA71590C2 (en) * | 1998-11-13 | 2004-12-15 | Duphar Int Res | Piperazine and piperidine derivatives |
-
2001
- 2001-10-25 KR KR10-2003-7006474A patent/KR20030065511A/ko not_active Application Discontinuation
- 2001-10-25 CZ CZ20031434A patent/CZ20031434A3/cs unknown
- 2001-10-25 PL PL01361462A patent/PL361462A1/xx unknown
- 2001-10-25 JP JP2002542363A patent/JP2004513915A/ja active Pending
- 2001-10-25 BR BR0115297-1A patent/BR0115297A/pt not_active IP Right Cessation
- 2001-10-25 SK SK639-2003A patent/SK6392003A3/sk not_active Application Discontinuation
- 2001-10-25 EP EP01996367A patent/EP1333821A2/en not_active Withdrawn
- 2001-10-25 AU AU2002221744A patent/AU2002221744A1/en not_active Abandoned
- 2001-10-25 CA CA002428519A patent/CA2428519A1/en not_active Abandoned
- 2001-10-25 WO PCT/EP2001/012325 patent/WO2002039988A2/en not_active Application Discontinuation
- 2001-10-25 HU HU0302761A patent/HUP0302761A2/hu unknown
- 2001-10-25 RU RU2003115433/15A patent/RU2283648C2/ru not_active IP Right Cessation
- 2001-10-25 MX MXPA03004249A patent/MXPA03004249A/es not_active Application Discontinuation
- 2001-10-25 US US10/416,575 patent/US20040014788A1/en not_active Abandoned
- 2001-10-25 CN CNA018188222A patent/CN1474688A/zh active Pending
- 2001-11-14 AR ARP010105302A patent/AR035503A1/es not_active Application Discontinuation
-
2003
- 2003-05-13 NO NO20032149A patent/NO20032149L/no not_active Application Discontinuation
- 2003-06-12 ZA ZA200304602A patent/ZA200304602B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030065511A (ko) | 2003-08-06 |
| AU2002221744A1 (en) | 2002-05-27 |
| CN1474688A (zh) | 2004-02-11 |
| US20040014788A1 (en) | 2004-01-22 |
| WO2002039988A3 (en) | 2002-07-25 |
| ZA200304602B (en) | 2004-09-13 |
| NO20032149D0 (no) | 2003-05-13 |
| JP2004513915A (ja) | 2004-05-13 |
| CA2428519A1 (en) | 2002-05-23 |
| EP1333821A2 (en) | 2003-08-13 |
| WO2002039988A2 (en) | 2002-05-23 |
| MXPA03004249A (es) | 2003-09-22 |
| PL361462A1 (en) | 2004-10-04 |
| SK6392003A3 (en) | 2003-11-04 |
| RU2283648C2 (ru) | 2006-09-20 |
| CZ20031434A3 (cs) | 2003-09-17 |
| BR0115297A (pt) | 2003-08-26 |
| AR035503A1 (es) | 2004-06-02 |
| HUP0302761A2 (hu) | 2003-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032797L (no) | Substituerte pyridoindoler som serotonin agonister og antagonister | |
| NO20041817L (no) | Arylanilin beta-2-adrenergisk reseptoragonister | |
| NO20040933L (no) | Nye gamma-sekretaseinhibitorer. | |
| DE60201437D1 (de) | 2,6-substituierte chromanderivate und ihre verwendung als beta-3 adrenorezeptor agonisten | |
| ATE359260T1 (de) | Substituierte cyclohexan-1,4-diaminderivate | |
| NO20034665L (no) | Nye forbindelser | |
| NO20026064L (no) | Nye forbindelser | |
| NO20023933L (no) | Nye forbindelser | |
| IS6566A (is) | Indólín-2-ón afleiður, framleiðsla og notkun þeirra sem mjaltavaka (ocytocin) viðtakabindlar | |
| NO20034970D0 (no) | Nye arylheteroalkylaminderivater | |
| NO20034773L (no) | Nye ftalazinoner | |
| DK1621198T3 (da) | Substituerede carbostyrilderivater som 5-HT1A-receptorsubtype-agonister | |
| AR028579A1 (es) | Metodo para el tratamiento de la sequedad vaginal, con agonistas del receptor de acetilcolina nicotinica | |
| ATE492535T1 (de) | 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren | |
| NO20026162L (no) | Nye forbindelser | |
| DE60224221D1 (de) | Aminotetralinderivate, antagonisten von muscarinrezeptoren | |
| DE60038911D1 (de) | 4-Phenylpiperazinyl, -piperidinyl und -tetrahydropyridyl-Derivate als Dopamin D4-Antagonisten | |
| NO20004271D0 (no) | Benzylpiperazinyl- og benzylpiperidinyl etanonderivater, deres fremstilling og deres anvendelse som dopamin D4 reseptorantagonister | |
| NO20020644D0 (no) | Nye integrinreseptor-antagonister | |
| NO20032149L (no) | Nye anvendelser av kombinerte, selektive dopamin D2- reseptorantagonister og5-HT1A-reseptoragonister | |
| NO20013709D0 (no) | Nye N-triazolylmetyl-piperazinderivater som neurokininreseptorantagonister | |
| NO20026081D0 (no) | Nye forbindelser | |
| DE60131556D1 (de) | Ringnetzwerk und datensender | |
| NO20032148D0 (no) | Nye anvendelser av kombinerte 5-HT1A-agonister og serotoningjenopptaksinhibitorer | |
| NO20025461D0 (no) | Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |